Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

53.57 +2.32 (+4.53%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

33 34 Next >

3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential ↗

November 21, 2025

These stocks have market caps of around $4 billion and $5 billion, and they could potentially double or triple in size in the long run.

Via The Motley Fool

Agios Pharmaceuticals Plunges Over 50% as Sickle Cell Drug Delivers Mixed Phase 3 Results

November 19, 2025

Boston, MA – November 19, 2025 – Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) experienced a dramatic and immediate market backlash, with its stock plummeting over 51.00% following the announcement of...

Via MarketMinute

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

November 19, 2025

These stocks both have advanced in the double-digits in recent months.

Via The Motley Fool

Retail Bulls Call CRISPR ‘Criminally Undervalued’ After Gene-Editing Breakthrough Cuts Cholesterol By 70% ↗

November 10, 2025

Via Stocktwits

How Is The Market Feeling About CRISPR Therapeutics? ↗

September 12, 2025

Via Benzinga

1 Underrated Stock That Could Soar by 58%, According to Wall Street ↗

November 17, 2025

This biotech has already made impressive contributions to medicine, and it could make more. But does that make it a buy?

Via The Motley Fool

The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market

November 14, 2025

The global financial markets are in the midst of a profound transformation, driven by an accelerating wave of technological advancements. From the intricate algorithms of Artificial Intelligence to the...

Via MarketMinute

ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried? ↗

November 12, 2025

ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried?

Via The Motley Fool

Topics Regulatory Compliance

CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial ↗

November 11, 2025

CRISPR Therapeutics' CTX310 trial shows strong, sustained lipid reductions and favorable safety, boosting confidence in its gene editing platform.

Via Benzinga

Why Gene-Editing Giants Crispr And Intellia Just Surged ↗

November 10, 2025

The companies are working on one-and-done treatments for diseases tied to genetic problems.

Via Investor's Business Daily

Topics Death

Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies ↗

November 07, 2025

The company remains confident in its other gene-editing product, which would treat a swelling disorder.

Via Investor's Business Daily

Topics Death

AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures

November 06, 2025

A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as...

Via TokenRing AI

Topics Artificial Intelligence Climate Change Intellectual Property

Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys ↗

November 04, 2025

Cathie Wood-led Ark Invest purchased shares in Bullish, a crypto exchange backed by Peter Thiel, through three of its funds. Other key trades were also made, including buying shares in CRISPR and Beam...

Via Benzinga

AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential

November 04, 2025

The burgeoning fields of cell and gene therapy (CGT) are on the cusp of a profound revolution, driven by the relentless advancements in artificial intelligence. This transformative impact was a central...

Via TokenRing AI

Topics Artificial Intelligence

Prediction: 2 Stocks That Will Be Worth More Than SoundHound AI 2 Years From Now ↗

November 04, 2025

It is a smart strategy to diversify your portfolio by investing in high-quality companies built on proven technologies.

Via The Motley Fool

Topics Artificial Intelligence

Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗

October 27, 2025

Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event.

Via Benzinga

2 Soaring Cathie Wood Stocks to Buy and Hold ↗

October 17, 2025

These companies' market-beating fuel hasn't run out yet.

Via The Motley Fool

New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar. ↗

October 16, 2025

CRISPR Therapeutics is a promising mid-cap biotech stock with an approved product in its portfolio.

Via The Motley Fool

3 Monster Stocks to Hold for the Next 10 Years ↗

October 15, 2025

Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the time. Every now and then, though, the right opportunity comes along.

Via The Motley Fool

4 Healthcare Stocks to Buy Now ↗

October 12, 2025

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Via The Motley Fool

Topics Artificial Intelligence

10 Health Care Stocks Whale Activity In Today's Session ↗

October 08, 2025

Via Benzinga

Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead ↗

October 08, 2025

These biotechs could finally come into their own by the end of the decade.

Via The Motley Fool

Topics Government World Trade

10 Health Care Stocks Whale Activity In Today's Session ↗

October 03, 2025

Via Benzinga

Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors

October 04, 2025

As of October 2025, the global financial markets are undergoing a profound transformation, driven by an accelerating wave of technological innovation and a pressing global imperative for...

Via MarketMinute

Topics Artificial Intelligence Climate Change Economy

3 Growth Stocks That Could Be 10-Baggers in 10 Years ↗

October 03, 2025

Air taxis, quantum computing, and gene editing are all promising technologies to invest in for the long haul.

Via The Motley Fool

Got $200? 2 Healthcare Stocks to Buy and Hold Forever ↗

October 01, 2025

These stocks could see growth take off over the next few years.

Via The Motley Fool

Could This Beaten-Down Stock Help You Become a Millionaire? ↗

September 30, 2025

The company would need to maintain the strong momentum it's had this year for a long time.

Via The Motley Fool

Topics ETFs

The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market

September 19, 2025

The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗

September 18, 2025

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of billions dollars in revenue.

Via Benzinga

Cathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190% ↗

September 11, 2025

These companies are reaching key milestones.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

Headline News about CRISPR Therapeutics AG - Common Shares

Starting at $3.75/week.

Subscribe Today